Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patientsMatt Liu, Jia‐Horng Kao, Min‐Sun Kwak et al.|Hepatology International|2021Cited by 33
Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohortYao‐Chun Hsu, Mindie H. Nguyen, Dae Won Jun et al.|Hepatology International|2022Cited by 27
Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B studyLung‐Yi Mak, Mindie H. Nguyen, Joseph Hoang et al.|Hepatology International|2021Cited by 23
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision MedicineJiyoon Park, Ming‐Lung Yu, An K. Le et al.|Clinical Gastroenterology and Hepatology|2021Cited by 16
Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational StudyMoon Haeng Hur, Jeong‐Hoon Lee, Min Kyung Park et al.|The American Journal of Gastroenterology|2023Cited by 13